| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.3 |
| Total income | 0.0 | 0.0 | 0.3 |
| Profit before exceptional items & tax | -0.1 | -0.1 | 0.0 |
| Profit before tax | -0.1 | -0.1 | 0.0 |
| Net profit | -0.1 | -0.1 | 0.0 |
| Operating margin | 0.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: HINDBIO. Figures extracted from the filing.
Hindustan Bio Sciences Ltd: key numbers
- Share price
- ₹7.10
- Market cap
- ₹7.28 Cr
- Revenue (annual)
- ₹0.74 Cr
- Net profit (annual)
- ₹-0.08 Cr
- P/E (TTM)
- -35.3×Sector 47.3×
- Promoter holding
- 12.19%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Bio Sciences Ltd
All →Hindustan Bio Sciences Annual General Meeting
Hindustan Bio Sciences Limited has issued a notice for its 34th Annual General Meeting to be held on September 30, 2026, in Hyderabad.
Hindustan Bio Sciences Annual Report
Hindustan Bio Sciences Ltd submitted its 34th Annual Report for FY 2025-26, containing the AGM notice proposing a scheme of capital reduction.
Hindustan Bio Sciences Merger & Restructuring
Hindustan Bio Sciences Ltd announced a capital reduction scheme to set off accumulated losses against its share capital. No cash consideration is paid to shareholders.
Hindustan Bio Sciences Board Meeting Date
Hindustan Biosciences scheduled a board meeting for August 31, 2026, to discuss the 34th AGM notice and a proposed scheme of share capital reorganization.
Hindustan Bio Sciences Board Meeting Date
Hindustan Bio Sciences Ltd scheduled a board meeting for July 31, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.
Hindustan Bio Sciences Q4 FY26 Results: Net Loss of ₹0.1 Cr
Hindustan Bio Sciences Ltd reported a net loss of ₹0.1 Cr for Q4 FY26.
- Key figure
- Net loss ₹0.1 Cr